1. zur Hausen H. Human papillomaviruses and their possible role in squamous cell carcinomas. Curr Top Microbiol Immunol 1977; 78: 1-30.

2. Castellsague X, Bosch FX, Munoz N. Environmental co-factors in HPV carcinogenesis. Virus Res 2002; 89(2): 191-199.

3. Mosher WD, Chandra A, Jones J. Sexual behavior and selected health measures: men and women 15-44 years of age, United States, 2002. Adv Data 362: 1-55, 2005.

4. Moscicki AB, Palefsky J, Gonzales J, Schoolnik G. Human papillomavirus infection in sexually active adolescent females: Prevalence and risk factors. PediatrRes 1990; 28: 507-513.

5. Rosenfeld WD, Vermund SH, Wentz SJ, et al. High prevalence rate of human papillomavirus infection and association with abnormal Papanicolaou smears in sexually active adolescents. Am J Dis Child 1989; 143: 1443-1447.

6. Singer A. The cervical epithelium during puberty and adolescence. In: The Cervix (Gordon JA, Singer A, eds.), WB Saunders, Philadelphia, 1978, 87.

7. Apter D, Viinikka L, Vihko R. Hormonal pattern of adolescent menstrual cycles. J Clin Endocrinol Metab 1978; 47(5): 944-954.

8. Mount SL, Papillo JL. A Study of 10,296 Pediatric and Adolescent Papanicolaou Smear Diagnoses in Northern New England. Pediatrics 1999; 103(3): 539-546.

9. American College of Obstetricians and Gynecologists. ACOG Guidelines for Women's Health Care. Washington, DC: The American College of Obstetricians and Gynecologists, 1996.

10. NIH. NIH releases consensus statement on cervical cancer. Am Fam Physician 1996; 54(7): 2310.

11. Elster, A. The American Medical Association Guidelines for Adolescent Preventive Services. Arch Pediatr Adolesc Med 1997; 151(9): 958-959.

12. Saslow D, Runowicz CD, Solomon D, et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin 2002; 52(6): 342-362.

13. Wright TCJ, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ. 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA 2002; 287(16): 2120-2129.

14. Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348(6): 518-527.

15. Crum CP, Genest DR, Krane JF, et al. Subclassifying atypical squamous cells in Thin-Prep cervical cytology correlates with detection of high-risk human papillomavirus DNA. Am J Clin Pathol 1999; 112(3): 384-390.

16. Moscicki AB, Ellenberg JH, Vermund SH, et al. Prevalence of and risks for cervical human papillo-mavirus infection and squamous intraepithelial lesions in adolescnt girls: impact of infection with human immunodeficiency virus. Arch Ped Adolesc Med 2000; 154: 127-134.

17. Ferreccio C, Prado RB, Luzoro AV, et al. Population-based prevalence and age distribution of human papillomavirus among women in Santiago, Chile. Cancer Epidemiol Biomarkers Prev 2004; 13(12): 2271-2276.

18. Herrero R, Hildesheim A, Bratti C, et al. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst 2000; 92(6): 464-474.

19. Moscicki AB, Hills N, Shiboski S, et al. Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. JAMA 2001; 285(23): 2995-3002.

20. Sadeghi SB, Hsieh EW, Gunn SW. Prevalence of cervical intraepithelial neoplasia in sexually active teenagers and young adults. Am J Obstet Gynecol 1984; 148: 726-729.

21. Bjorge T, Gunbjorud AB, Langmark F, Skare GB, Thoresen SO. Cervical Mass Screening in Norway—510,000 Smears a Year. Cancer Detection Prev 1994; 18(6): 463-470.

22. Schydlower LTM, Greenberg MH, Patterson CPH. Adolescents with Abnormal Cervical Cytology. Clin Pediatr 1981; 20(11): 723-726.

23. Green J, Berrington de Gonzalez A, Sweetland S, et al. Risk factors for adenocarcinoma and squamous cell carcinoma of the cervix in women aged 20-44 years: the UK National Case-Control Study of Cervical Cancer. Br J Cancer 2003; 89(11): 2078-2086.

24. Singer A. The uterine cervix from adolescence to the menopause. Br J Obstet Gynaecol 1975; 82(2): 81-99.

25. Moscicki AB, Ma Y, Holland C, Vermund SH. Cervical ectopy in adolescent girls with and without human immunodeficiency virus infection. J Infect Dis 2001; 183(6): 865-870.

26. Taichmain LB, LaPorta RF. The expression of papillomaviruses in epithelial cells. In: The papo-vaviridae (Salzman NP, ed.), The Papillomaviruses. New York, Plenum, 1986, vol. 2, pp. 109-130.

27. Longworth MS, Laimins LA. Pathogenesis of Human Papillomaviruses in Differentiating Epithelia. Microbiol Mol Biol Rev 2004; 68(2): 362-372.

28. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002; 287(16): 2114-2119.

29. Moscicki AB, Grubbs-Burt V, Kanowitz S, Darragh T, Shiboski S. The significance of squamous metaplasia in the development of low grade squamous intra-epithelial lesions in young women. Cancer 1999; 85: 1139-1144.

30. Schachter J, Hill EC, King EB, Coleman VR, Jones P, Meyer KF. Chlamydial infection in women with cervical dysplasia. Am J Obstet Gynecol 1975; 123(7): 753-757.

31. Moscicki AB, Shiboski S, Broering J, et al. The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr 1998; 132: 277-284.

32. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural History of cervicovaginal papillomavirus infection in young women. NEJM 1998; 338(7): 423-428.

33. Evander M, Edlund K, Gustaffson A, et al. Human Papillomavirus Infection is Transient in Young Women: A Population-Based Cohort Study. J Infect Dis 1995; 171: 1026-1030.

34. Moscicki AB, Ellenberg JH, Farhat S, Xu J. Persistence of human papillomavirus infection in HIV-infected and -uninfected adolescent girls: risk factors and differences, by phylogenetic type. J Infect Dis 2004; 190(1): 37-45.

35. Koutsky LA, Holmes KK, Critchlow CW, et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. NEJM 1992; 327: 1272-1278.

36. Brown FM, Faquin WC, Sun D, Crum CP, Cibas ES. LSIL biopsies after HSIL smears. Correlation with high-risk HPV and greater risk of HSIL on follow-up. Am J Clin Pathol 1999; 112(6): 765-768.

37. Syrjanen K, Kataja V, Yliskoski, Chang F, Syrjanen S. Natural History of Cervical Human Papillomavirus Lesions Does Not Substantiate the Biologic Relevance of the Bethesda System. Obstet Gynecol 1992; 79: 675-682.

38. Nassiel K, Nassiel M, Vaclavinkova V. Behavior of Moderate Cervical Dysplasia During Long Term Follow-Up. Obstet Gynecol 1983; 61: 609-614.

39. Nash JD, Burke TW, Hoskins WJ. Biologic course of cervical human papillomavirus infection. Obstet Gynecol 1987; 69: 160-162.

40. Moscicki AB, Shiboski S, Hills NK, et al. Regression of low-grade squamous intra-epithelial lesions in young women. Lancet 2004; 364(9446): 1678-1683.

41. Lee SS, Collins RJ, Pun TC, Cheng DK, Ngan HY. Conservative treatment of low grade squamous intraepithelial lesions (LSIL) of the cervix. Int J Gynaecol Obstet 1998; 60(1): 35-40.

42. Schlecht NF, Platt RW, Duarte-Franco E, et al. Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia. J Natl Cancer Inst 2003; 95(17): 1336-1343.

43. Cox JT, Schiffman M, Solomon D. ASCUS-LSIL Triage Study (ALTS) Group. Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy. Am J Obstet Gynecol 2003; 188(6): 1406-1412.

44. Woodman CB, Collins S, Winter H, et al. Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet 2001; 357(9271): 1831-1836.

45. Wright JD, Davila RM, Pinto KR, et al. Cervical dysplasia in adolescents. Obstet Gynecol 2005; 106(1): 115-120.

46. Ries LAG, Harkins D, Krapcho M, et al. SEER Cancer Statistics Reivew, 1975-2003, National Cancer Institute, Bethesda, MD,, based on November 2005 SEER data submission, posted to the SEER web site, 2006.

47. Moscicki AB, Millstein SG, Broering J, Irwin CE. Risks of human immunodeficiency virus infection among adolescents attending three diverse clinics. J Pediatr 1993; 122: 813-820.

48. Shafii T, Burstein GR. An overview of sexually transmitted infections among adolescents. Adolesc Med Clin 2004; 15(2): 201-214.

49. ASCUS-LSIL Traige Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 2003; 188(6): 1383-1392.

49a. National Health Services Cancer Screening Programme, [email protected]/cer-vical.index.html#invited.

49b. National Health and Medical Research Council Guidelines Screening to prevent cervical cancer,

50. Smith JS, Green J, Berrington de Gonzalez A, et al. Cervical cancer and use of hormonal contraceptives: a systematic review. Lancet 2003; 361(9364): 1159-1167.

51. Smith JS, Bosetti C, Munoz N, et al. Chlamydia trachomatis and invasive cervical cancer: a pooled analysis of the IARC multicentric case-control study. Int J Cancer 2004; 111(3): 431-439.

52. Moscicki AB, Ellenberg JH, Crowley-Nowick P, Darragh TM, Xu J, Farhat S. Risk of high grade squamous intra-epithelial lesions in HIV infected adolescents. J Infect Dis 2004; 190(8): 1413-1421.

53. Centers For Disease Control. USPHS/IDSA Guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: A summary. Morb Mortal Wkly Rep 1995; 44: 1-34.

10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook

Post a comment